Old Web
English
Sign In
Acemap
>
authorDetail
>
T. Keler
T. Keler
Cancer research
Medicine
Dendritic cell
Antibody
Immunology
5
Papers
74
Citations
0.01
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (5)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
A prime/boost vaccine platform efficiently identifies CD27 agonism and depletion of myeloid-derived suppressor cells as therapies that rationally combine with checkpoint blockade in ovarian cancer.
2021
Cancer Immunology, Immunotherapy
A. J. R. McGray
Cheryl Eppolito
Anthony Miliotto
Kelly L. Singel
Kyle B. Stephenson
Amit A. Lugade
Brahm H. Segal
T. Keler
G. Webster
Brian D. Lichty
Danuta Kozbor
K. Odunsi
Show All
Source
Cite
Save
Citations (0)
430 Intradermal injection of antigen: Antibody fusion proteins directed against lectin receptors targets defined dendritic cell subsets in human skin and elicits T cell responses
2016
Journal of Investigative Dermatology
Lydia Bellmann
Sandra Schaffenrath
B. del Frari
Kerstin Komenda
Gabriel Djedovic
J. Rühl
C. Münz
T. Keler
Patrizia Stoitzner
Nikolaus Romani
Show All
Source
Cite
Save
Citations (0)
Antibody-targeted vaccines
2007
Oncogene
T. Keler
L. He
V. Ramakrishna
B Champion
Show All
Source
Cite
Save
Citations (26)
MDX-010 (human anti-CTLA4): a phase I trial in malignant melanoma
2002
S Tchekmedyian
J Glaspy
A. Korman
T. Keler
Yashwant M. Deo
Thomas A. Davis
Show All
Source
Cite
Save
Citations (48)
Effect of endotoxin on isolated osteoblast like cells
1986
J. Brand
F. Sanavi
E. Kováts
T. Keler
J. Samu
A Nowotny
Show All
Source
Cite
Save
Citations (0)
1